Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT05917821
New Antigens Against Glioblastoma
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
View on ClinicalTrials.gov
Summary
In this study the investigators will select and develop potential therapeutic monoclonal antibodies (mAbs) for glioblastoma (GB). Activities include tissue microarray (TMA) to test monoclonal antibodies specificity and target distribution, selection of glioblastoma specific functional monoclonal antibodies, identification of candidate targets.
Official title: Identification of New Antigens Against Glioblastoma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
120
Start Date
2023-08-01
Completion Date
2027-09-30
Last Updated
2023-07-24
Healthy Volunteers
Not specified